Acute Service Redesign Award - HSJ Value Awards 2019
Acute services often develop organically, with changes and improvements bolted on to existing models over time. While this may enable services to evolve to meet changing needs, it may fail to take advantage of potential efficiency gains or may even result in a net efficiency reduction. Other potential side effects include the prioritisation of savings over quality or the absence of focus on the needs and preferences of patients.
Even the most successful services therefore benefit from periodic review and, where necessary, redesign to ensure they are fit for purpose and deliver high quality care in an efficient and cost-effective manner.
This award recognises individuals or teams in the NHS – or independent and private sector organisations working with the NHS – that have led the successful redesign of an acute service.
- A clear rationale for the project
- An explanation of how it aimed to achieve improved value in the delivery of acute services
- An explanation of how the redesign plan was informed by existing best practice or evidence
- An explicit focus on patient safety alongside efficiency improvements
Evidence that the project has led to improved value in the delivery of acute services. This should include a quantitative aspect – for instance, demonstrable reductions in average length of stay, improved patient outcomes, reductions in avoidable admissions, fewer delayed transfers of care – and can also include qualitative aspects such as patient experience measures.
Proof the project met or surpassed its original goal
Initiatives that have embedded and spread beyond their original setting to other departments, settings or organisations or clear evidence the work is potentially replicable and scalable
Clear evidence the redesign has improved value in acute services. Of interest will be projects that have simultaneously delivered financial savings and improved patient experience – creating value for taxpayers and patients alike. Quantitative evidence of improved value should be supplied.
Clear evidence all relevant parties were involved in the redesign, including patients